Shunwei backs Ultron Photonics and 13 more deal updates from Greater China dealstreetasia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dealstreetasia.com Daily Mail and Mail on Sunday newspapers.
China Digest: Dearer nets $65m; Temasek backs Abiochem
Dearer nets $65m in Series B
Shanghai-headquartered contact lens manufacturer Dearer has raised 420 million yuan ($65 million) in a Series B round of financing.
State-backed alternative asset manager CITIC Private Equity Funds Management (CPE), Legend Holdings’ investment arm Legend Capital and BioTrack Capital joined the round. Insight Capital made a follow-on investment in the round.
The company will use the proceeds for R&D and mass production of coloured contact lenses, the company said in a statement.
Its early-stage investors include Orient Securities, Borchid Capital, FOF Capital and eyecare service provider Eyebright.
Temasek invests in Abiochem
China Digest: Bluepha, Youye Technology in funding news
Photo: Pixabay
February 26, 2021
Bluepha has secured nearly $200 million yuan ($30 million) in its Series B round of funding co-led by Hillhouse Capital and Lightspeed China Partners. In a separate development, Youye Technology has raised nearly $100 million in a strategic investment.
Bluepha nets nearly $30m in Series B
Beijing-headquartered synthetic biology firm Bluepha has secured nearly $200 million yuan ($30 million) in its Series B round of funding co-led by Asia-focused PE firm Hillhouse Capital and early-stage investor Lightspeed China Partners, per a company statement on Friday.
The latest round also saw the participation of Chinese apparel conglomerate Septwolves’ investment arm, and Trinity Innovation Fund.